These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 11331054

  • 1. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.
    Schepkens H, Vanholder R, Billiouw JM, Lameire N.
    Am J Med; 2001 Apr 15; 110(6):438-41. PubMed ID: 11331054
    [Abstract] [Full Text] [Related]

  • 2. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A.
    J Am Geriatr Soc; 2002 Jul 15; 50(7):1297-300. PubMed ID: 12133029
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [An elderly man with known heart failure admitted with cardiogenic shock].
    Hovland A, Fagerheim AK, Hardersen R, Nielsen EW.
    Tidsskr Nor Laegeforen; 2010 Jul 01; 130(13):1352-4. PubMed ID: 20596117
    [Abstract] [Full Text] [Related]

  • 6. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
    Erden I, Yalcin S, Ozhan H.
    Kardiol Pol; 2010 Sep 01; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).
    Am J Cardiol; 1996 Oct 15; 78(8):902-7. PubMed ID: 8888663
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
    Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA.
    N Engl J Med; 2004 Aug 05; 351(6):543-51. PubMed ID: 15295047
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
    Dutka M, Dzielski T, Wojciechowska J, Heller L, Trybus M.
    Pol Merkur Lekarski; 1999 Aug 05; 7(38):69-70. PubMed ID: 10522422
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R, McMurray JJ, Swedberg K, van Veldhuisen DJ, Krum H, Pocock SJ, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B, EMPHASIS-HF Investigators.
    J Am Coll Cardiol; 2013 Oct 22; 62(17):1585-93. PubMed ID: 23810881
    [Abstract] [Full Text] [Related]

  • 16. Life-threatening hyperkalemia during a combined therapy with the angiotensin receptor blocker candesartan and spironolactone.
    Fujii H, Nakahama H, Yoshihara F, Nakamura S, Inenaga T, Kawano Y.
    Kobe J Med Sci; 2005 Oct 22; 51(1-2):1-6. PubMed ID: 16199929
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone.
    Cruz CS, Cruz AA, Marcílio de Souza CA.
    Nephrol Dial Transplant; 2003 Sep 22; 18(9):1814-9. PubMed ID: 12937229
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP, Aaronson KD, Koelling TM.
    Am Heart J; 2004 Dec 22; 148(6):971-8. PubMed ID: 15632880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.